Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis
- 1 November 1995
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 64 (5) , 903-908
- https://doi.org/10.1016/s0015-0282(16)57900-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Gonadotropin-Releasing Hormone Agonists: Treatment of EndometriosisClinical Obstetrics and Gynecology, 1993
- An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosisFertility and Sterility, 1992
- Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Gonadotropin-releasing hormone agonists: Strategies formanaging the hypoestrogenic effects of therapyAmerican Journal of Obstetrics and Gynecology, 1992
- Hormone treatment of endometriosis: The estrogenthreshold hypothesisAmerican Journal of Obstetrics and Gynecology, 1992
- Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapyAmerican Journal of Obstetrics and Gynecology, 1990
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.Journal of Clinical Endocrinology & Metabolism, 1982